Other OTC - Delayed Quote USD

Nanalysis Scientific Corp. (NSCIF)

0.3500 0.0000 (0.00%)
As of May 13 at 1:37 PM EDT. Market Open.
Loading Chart for NSCIF
DELL
  • Previous Close 0.3500
  • Open 0.3500
  • Bid --
  • Ask --
  • Day's Range 0.3500 - 0.3500
  • 52 Week Range 0.2510 - 0.4950
  • Volume 10,000
  • Avg. Volume 98,551
  • Market Cap (intraday) 39.388M
  • Beta (5Y Monthly) 0.76
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1200
  • Earnings Date May 23, 2024 - May 27, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada.

www.nanalysis.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NSCIF

Performance Overview: NSCIF

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NSCIF
25.90%
S&P/TSX Composite index
6.14%

1-Year Return

NSCIF
19.41%
S&P/TSX Composite index
8.94%

3-Year Return

NSCIF
11.88%
S&P/TSX Composite index
16.25%

5-Year Return

NSCIF
--
S&P/TSX Composite index
60.05%

Compare To: NSCIF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NSCIF

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    39.07M

  • Enterprise Value

    54.57M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.67

  • Price/Book (mrq)

    2.29

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -56.90%

  • Return on Assets (ttm)

    -13.67%

  • Return on Equity (ttm)

    -47.24%

  • Revenue (ttm)

    28.47M

  • Net Income Avi to Common (ttm)

    -16.2M

  • Diluted EPS (ttm)

    -0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    759k

  • Total Debt/Equity (mrq)

    93.56%

  • Levered Free Cash Flow (ttm)

    -8M

Research Analysis: NSCIF

Company Insights: NSCIF

Research Reports: NSCIF

People Also Watch